LINC01917

Across TCGA pan-cancer cohorts, LINC01917 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC01917 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LINC01917 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC01917 expression acts as an unfavorable survival marker, although some lineages such as KIRP and PAAD show a favorable association.

KIRP, ACC, and COAD are the cancer types where LINC01917 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Quartile	All	0.979	0.827	.003	57	view →
ACC	DFS	Tertile	IV	0.056	0.404	.003	57	view →
COAD	OS	Tertile	II,III,IV	0.732	0.867	.005	27	view →
HNSC	DFS	Tertile	II,III,IV	0.493	0.637	.011	24	view →
STAD	DFS	Quartile	IV	0.248	0.545	.018	21	view →
LGG	DFS	Tertile	All	0.245	0.421	<.001	21	view →
PAAD	DFS	Tertile	All	0.590	0.200	.003	18	view →
TGCT	DFS	Tertile	II,III,IV	0.621	0.949	.034	18	view →
PRAD	OS	Tertile	All	0.952	0.995	<.001	18	view →
SKCM	DFS	Tertile	IV	0.040	0.620	.003	12	view →
SARC	DFS	Tertile	All	0.415	0.647	.004	9	view →
LUAD	DFS	Tertile	III,IV	0.407	0.271	.035	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LINC01917–KIRP (DFS)

Open the KIRP breakdown →